Sterling Capital Management LLC Decreases Stock Holdings in Xylem Inc. $XYL

Sterling Capital Management LLC reduced its stake in shares of Xylem Inc. (NYSE:XYL) by 43.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,197 shares of the industrial products company’s stock after selling 6,230 shares during the period. Sterling Capital Management LLC’s holdings in Xylem were worth $980,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XYL. Knuff & Co LLC acquired a new position in Xylem during the third quarter worth $27,000. Board of the Pension Protection Fund acquired a new stake in shares of Xylem in the 4th quarter worth $27,000. Commonwealth Retirement Investments LLC acquired a new stake in shares of Xylem in the 4th quarter worth $27,000. Wexford Capital LP purchased a new position in shares of Xylem during the 3rd quarter worth $27,000. Finally, Ramirez Asset Management Inc. boosted its position in shares of Xylem by 100.0% during the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after acquiring an additional 100 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

NYSE:XYL opened at $118.23 on Wednesday. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The company has a 50 day moving average price of $112.82 and a 200 day moving average price of $125.00. The stock has a market capitalization of $28.10 billion, a P/E ratio of 29.41, a PEG ratio of 1.66 and a beta of 1.04.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the prior year, the firm earned $1.03 earnings per share. The firm’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts forecast that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s dividend payout ratio is presently 42.79%.

Insider Transactions at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. The trade was a 54.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were acquired at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on XYL. UBS Group upped their price objective on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Oppenheimer decreased their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Stifel Nicolaus dropped their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. JPMorgan Chase & Co. reduced their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Finally, Barclays lowered their price objective on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $153.54.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.